INTRODUCTION
death, tumor, liver cancer, blood loss, portal vein tumor thrombus, HCC, intrahepatic tumors
TUMOR, RECURRENCE, LIVER CANCER, BLOOD LOSS, HEPATOCELLULAR CARCINOMA, EVENTS
The most prevalent type of liver cancer is hepatocellular carcinoma (HCC), which is also one of the top causes of cancer‐related death globally.Postoperative recurrence patterns vary among patients. In general, approximately 80% of HCC cases recur intrahepatically, including solitary intrahepatic and multiple intrahepatic tumors.When compared to HCC without EHR, postsurgical EHR is multifactorial and may exhibit poor biological behavior. Studies have indicated that the development of postsurgical EHR of HCC is influenced by multiple clinicopathological features, including large tumor size, high AFP level, incomplete tumor capsule, portal vein tumor thrombus (PVTT)/MVI status, positive for HBsAg, high blood loss during surgery, as well as some molecular events (e.g., P53 mutations and CD44v3 expression).